Keytruda Qlex

Keytruda Qlex is a medication used to treat various types of cancer, including melanoma, non-small cell lung cancer, and certain other solid tumors. It works by helping the body's immune system recognize and fight cancer cells more effectively. This medication is given as a subcutaneous injection, typically every three weeks at a starting dose of 395 mg or every six weeks at 790 mg, depending on the treatment plan. It is important to know that Keytruda Qlex should not be used if you have a known allergy to its components, such as berahyaluronidase alfa. Additionally, patients taking other medications that suppress the immune system should discuss this with their healthcare provider, as it may affect how well Keytruda Qlex works.